Business Description
Cabaletta Bio Inc
NAICS : 325412
SIC : 2834
ISIN : US12674W1099
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 27.46 | |||||
Equity-to-Asset | 0.92 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.08 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -7.4 | |||||
3-Year EPS without NRI Growth Rate | -4.6 | |||||
3-Year FCF Growth Rate | -3.8 | |||||
3-Year Book Growth Rate | 3.8 | |||||
Future 3-5Y EPS without NRI Growth Rate | -13.76 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 0.52 | |||||
9-Day RSI | 1.75 | |||||
14-Day RSI | 5.34 | |||||
6-1 Month Momentum % | -76.24 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 11.52 | |||||
Quick Ratio | 11.52 | |||||
Cash Ratio | 11.35 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -24.4 | |||||
Shareholder Yield % | -3.44 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -45.33 | |||||
ROA % | -42.07 | |||||
ROIC % | -581.07 | |||||
ROC (Joel Greenblatt) % | -1268.2 | |||||
ROCE % | -50.14 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.05 | |||||
Price-to-Tangible-Book | 1.05 | |||||
EV-to-EBIT | -0.06 | |||||
EV-to-EBITDA | -0.06 | |||||
EV-to-FCF | -0.21 | |||||
Price-to-Net-Current-Asset-Value | 1.11 | |||||
Price-to-Net-Cash | 1.13 | |||||
Earnings Yield (Greenblatt) % | -1570.57 | |||||
FCF Yield % | -37.24 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Cabaletta Bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil MXN) | |||
EPS (TTM) (MXN) | -33.225 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 5.34 | ||
14-Day ATR (MXN) | 0.211517 | ||
20-Day SMA (MXN) | 71.76 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (MXN) | 71.76 - 418.23 | ||
Shares Outstanding (Mil) | 48.85 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cabaletta Bio Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cabaletta Bio Inc Stock Events
Event | Date | Price(MXN) | ||
---|---|---|---|---|
No Event Data |
Cabaletta Bio Inc Frequently Asked Questions
What is Cabaletta Bio Inc(MEX:CABA)'s stock price today?
When is next earnings date of Cabaletta Bio Inc(MEX:CABA)?
Does Cabaletta Bio Inc(MEX:CABA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |